Genmark Diagnostics reported $19.4M in Gross Profit on Sales for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 5276M 780M
Accelerate Diagnostics AXDX:US 897K 251K
Agilent A:US $ 817M 21M
Bruker BRKR:US $ 280.6M 1.9M
Danaher DHR:US $ 4397M 144M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Hologic HOLX:US $ 701.6M 384.2M
Illumina ILMN:US $ 764M 134M
Laboratory Of America LH:US $ 1264.8M 334.2M
Luminex LMNX:US $ 66.46M 2.02M
Mesa Laboratories MLAB:US $ 24.74M 4.08M
Myriad Genetics MYGN:US $ 107.5M 6.5M
Nanostring Technologies NSTG:US $ 15.99M 3.55M
Orasure Technologies OSUR:US $ 38.33M 0.14M
Oxford Immunotec Global OXFD:US $ 14.86M 11.19M
Pacific Biosciences Of California PACB:US $ 12.98M 1.58M
Perkinelmer PKI:US $ 685.19M 99.95M
Quest Diagnostics DGX:US $ 997M 108M
Quidel QDEL:US $ 301.96M 399.54M
Siemens SIE:GR 5.24B 81M
Thermo Fisher Scientific TMO:US $ 4688M 521M
Veracyte VCYT:US $ 37.63M 13.33M
Waters WAT:US $ 354.4M 111.69M